Search

everythinglearnresearchcommunity

for

Search:↓

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Blocking IL-17 can reduce skin inflammation in a mouse model of pityriasis rubra pilaris.

A medication may help with hair growth in psoriasis, and a skin condition might be linked to a specific bacteria.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

An elderly man's hair grew back after treatment with secukinumab, possibly due to reduced scalp inflammation or the medication's direct effects.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

Ixekizumab may be an effective first treatment for a rare skin condition causing hair loss.

Ixekizumab successfully treated a rare hair loss condition, leading to complete hair regrowth.

Brodalumab effectively treated a man's severe hand and foot psoriasis.

Certain immune system proteins are important for skin healing but can cause problems if there are too many of them.

Two patients with psoriasis grew extra hair after using certain psoriasis medications.

A specific immune response helps control mite populations on the skin, maintaining healthy hair follicles.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.

Biologics show promise in treating various stubborn skin diseases, but more research and better reimbursement criteria are needed.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

IL-1 family cytokines are crucial for skin defense and healing, but their imbalance can cause skin diseases.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

IL-3 worsens lupus nephritis and blocking it improves kidney health.

TNF-alpha inhibitors can cause various immune-related skin issues.

Some skin conditions may increase the risk of heart disease, but are not yet included in cardiovascular prevention guidelines.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

A protein called IL-36γ causes skin side effects from certain cancer treatments when combined with a common skin bacteria.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.